Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
This week on Lifers, Christina Farr is joined by Farzad Mostashari, CEO of Aledade and former National Coordinator for Health IT, alongside co-host Mike Desjadon, CEO of Anomaly Health.
![[Emergency Pod] Peptides - Part 2 with Dr. Jonathan Slotkin of Scrub Capital](https://storage.ghost.io/c/32/92/329223b2-d42a-458e-900a-bdc42bd462a7/content/images/size/w960/format/webp/2026/04/4c028527c5cedaa3c7be6f91f31d12db.png)
In this special episode of Lifers, Christina Farr sits down with Dr. Jonathan Slotkin (neurosurgeon, CMO, and co-founder of
![[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight](https://storage.ghost.io/c/32/92/329223b2-d42a-458e-900a-bdc42bd462a7/content/images/size/w960/format/webp/2026/04/d530aaba2d069cc996de2cbebbccae27.png)
Christina Farr sits down with Sunita Mohanty, CEO and Co-founder of Ultralight, an AI-native operating system powering over
Second Opinion partnered with Confido to determine which companies should make the cut.
There's a lot more of them than we expected!
Ruth here again. This week, I’m paying attention to a white paper that says health systems have a hard
Ruth Reader here, again! Obviously, the news of the week is The New York Times profile of Medvi, a virtual
On this special mini episode of Lifers, Christina Farr speaks with Josh Tauber, multi-time COO and founder, and Keaton Bedell, co-founder and CEO of Bridge, about a recent New York Times article on Medvi, a cash-pay GLP-1 company valued at $1.8 billion.
A new meta-analysis in SpringerNature shows what researchers have long said about Epic’s artificial intelligence: its out-of-
